Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location | |
|---|---|---|---|---|
LATAM LOWERS LDL-C |
Hypercholesterolaemia | Phase4 | Argentina Brazil |
NCT06501443 |
Specified Drug-use Surveillance of Fabhalta Capsules |
Paroxysmal Nocturnal Hemoglobinuria | Japan | NCT06606314 | |
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B) |
Healthy Volunteers, Pulmonary Arterial Hypertension | Phase1, Phase2 | Australia Latvia Portugal Romania United States View all |
NCT06649110 |
Kesimpta (Ofatumumab) Pregnancy Registry |
Multiple Sclerosis, Pregnancy | United States | NCT05634967 | |
Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer |
Prostatic Neoplasms, Castration-Resistant | Phase1 | Australia South Africa |
NCT04597411 |
Kesimpta Pregnancy and Infant Safety Study Using Real World Data |
Multiple Sclerosis | Switzerland | NCT06156683 | |
Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent |
Multiple Sclerosis | United States | NCT04933552 | |
Regulatory Post-Marketing Surveillance Study for Brolucizumab |
Neovascular Age-related Macular Degeneration | South Korea | NCT04985487 | |
A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Korea |
Graft-versus-Host Disease | South Korea | NCT05621733 | |
Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria |
Uncomplicated Plasmodium Falciparum Malaria | Phase2 | Burkina Faso Côte d’Ivoire Gabon Ghana Kenya Uganda View all |
NCT05750628 |